NCT00972725View on ClinicalTrials.gov

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

PHASE2CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

December 1, 2009

Primary Completion Date

October 4, 2010

Study Completion Date

October 4, 2010

Conditions

AIDS

Interventions

BIOLOGICAL

GSK Biologicals' HIV vaccine (732461)

1 dose intramuscular injection

DRUG

Chloroquine

One dose of 300 mg

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00972725 - Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose | Biotech Hunter | Biotech Hunter